Recent advances in the treatment of eosinophilic esophagitis.
First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of the current literature on EoE has been published in the last 3 years, signaling both a rising incidence and increased recognition of this disorder. Treatment options available for patients with EoE include dietary management and/or pharmacologic therapy. An individualized approach to treatment is preferred, with an emphasis on patient-parental preference. The objective of this article is to discuss the current and future treatment options for EoE.
Schroeder
Shauna
S
University of Colorado Denver School of Medicine, Denver, CO, USA; The Children's Hospital Denver, 13123 East 16th Avenue, B290, Aurora, CO 80016, USA.
Atkins
Dan
D
Furuta
Glenn T
GT
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004035:Diet Therapy / Q000639:trends; D057765:Eosinophilic Esophagitis / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D018793:Interleukin-13 / Q000276:immunology; D015848:Interleukin-5 / Q000276:immunology; D009092:Mucous Membrane / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D057240:Patient Preference; D057285:Precision Medicine; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D058408:Th1-Th2 Balance / Q000187:drug effects
D000911:Antibodies, Monoclonal; D018793:Interleukin-13; D015848:Interleukin-5; D054328:Proton Pump Inhibitors